Indication
Metastatic Appendiceal Adenocarcinoma
1 clinical trial
3 products
1 drug
Clinical trial
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal AdenocarcinomaStatus: Recruiting, Estimated PCD: 2026-01-02
Product
DexamethasoneProduct
DiphenhydramineProduct
FamotidineDrug
Tiragolumab